Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Psychooncology. 2018 Sep 27;27(12):2761–2769. doi: 10.1002/pon.4883

Table 2.

Adjusted Mean (SD) Symptom Cluster Outcomes by Group and Time (N=161)

CBS Intervention
MAdj (95% CI)
 Attention-Control
MAdj (95% CI)
 Adjusted Mean
Difference
(95% CI)		 p-value
(1-tailed)
Symptom
Cluster Severity
 Week 3 3.55(3.11, 4.00) 3.74(3.34, 4.14) −.19(−.74, .36) .25
 Week 6 3.61(3.06, 4.15) 3.71(3.22, 4.20) −.11(−.78, .57) .38
 Week 9 3.36(2.80, 3.91) 3.71(3.21, 4.21) −.36(−1.04, .33) .15
Symptom
Cluster Distress
 Week 3 1.94(1.67, 2.21) 2.07(1.83, 2.31) −.13(−.46, .20) .22
 Week 6 1.82(1.52, 2.12) 2.15(1.88, 2.42) −.33(−.70, .04) .04
 Week 9 1.87(1.57, 2.16) 1.99(1.72, 2.26) −.12(−.49, .25) .26
Symptom
Cluster
Interference
 Week 3 3.97(3.22, 4.71) 4.48(3.79, 5.16) −.51(−1.45, .42) .14
 Week 6 3.68(2.99, 4.37) 4.25(3.62, 4.89) −.57(−1.44, .30) .10
 Week 9 3.83(3.04, 4.62) 4.15(3.42, 4.88) −.32(−1.31, .67) .26

Adjusted for baseline score, age, education, depression, and number of supportive medications